US biotech industry welcomes proposed change to price negotiation power

February 27, 2025 Latest News BioPharma

This is a preview of subscriber content

Subscribe now to continue reading.

"This bipartisan legislation will eliminate the pill penalty and help ensure science and researchers – not government bureaucrats – determine the possible treatments innovator companies pursue," said BIO CEO and president John Crowley. …

Subscribe now to continue reading.

Latest Video

BMS says September outcome could set a new policy benchmark for access
October 18, 2025 - Latest News
Trump announces third MFN deal with a focus on fertility drug costs and expanding IVF access
October 18, 2025 - Latest News
An exceptional outcome that must not become an exception
October 18, 2025 - Latest News
Landmark trial confirms survival benefit of Lilly therapy in high-risk early breast cancer
October 18, 2025 - Latest News
New combination therapy sets landmark survival benchmark in bladder cancer treatment
October 19, 2025 - Latest News

US biotech industry welcomes proposed change to price negotiation power

This is a preview of subscriber content

Latest Video

Most Read

BMS says September outcome could set a new policy benchmark for access

Trump announces third MFN deal with a focus on fertility drug costs and expanding IVF access

An exceptional outcome that must not become an exception

Landmark trial confirms survival benefit of Lilly therapy in high-risk early breast cancer

New combination therapy sets landmark survival benchmark in bladder cancer treatment

New Stories

Immutep unveils dual breakthroughs at ESMO 2025, strengthening case for Efti across multiple tumour types

Pharmac targets red tape to streamline access to some medicines and health consumables

Australia records worst flu season on record as vaccination rates stagnate

Merck expands commitment to first nations STEM leadership with new scholarships and partnerships

Orthocell boosts balance sheet with capital raise to drive nerve repair product growth

Amplia targets US market expansion as FAK inhibitor shows promise in pancreatic cancer

New combination therapy sets landmark survival benchmark in bladder cancer treatment

Sign In

US biotech industry welcomes proposed change to price negotiation power

This is a preview of subscriber content

Latest Video

Most Read

BMS says September outcome could set a new policy benchmark for access

Trump announces third MFN deal with a focus on fertility drug costs and expanding IVF access

An exceptional outcome that must not become an exception

Landmark trial confirms survival benefit of Lilly therapy in high-risk early breast cancer

New combination therapy sets landmark survival benchmark in bladder cancer treatment

Follow Us

New Stories

Immutep unveils dual breakthroughs at ESMO 2025, strengthening case for Efti across multiple tumour types

Pharmac targets red tape to streamline access to some medicines and health consumables

Australia records worst flu season on record as vaccination rates stagnate

Merck expands commitment to first nations STEM leadership with new scholarships and partnerships

Orthocell boosts balance sheet with capital raise to drive nerve repair product growth

Amplia targets US market expansion as FAK inhibitor shows promise in pancreatic cancer

New combination therapy sets landmark survival benchmark in bladder cancer treatment